Jonathan Burlison, Ph.D., is the Patient Safety Project manager in the Pharmaceutical Sciences Department at St. Jude Children’s Research Hospital.
Dr. Justin N. Baker shares lessons on compassion from his experience at St. Jude. Watch his TEDx Memphis talk to learn how to help others through difficult times, and know why it matters.
Dr. Josh Wolf explains how biostatistics resolved safety questions on preemptive vancomycin for acute myeloid leukemia patients after chemotherapy.
Many adolescents fail to get a key vaccination that can prevent cancer. Learn what doctors know about the HPV cancer vaccine.
Myelodysplastic syndromes can lead to leukemia in children. Considered an adult disease, researchers have found molecular differences that may offer new treatments for children with pediatric MDS.
Learn how breastfeeding helps childhood cancer survivors reduce late effects, the health problems that occur months or years after treatment.
The most important part of research is that you must not fool yourself — and you’re the easiest person to fool.
Read how the oncogene MYCN hijacks an oxygen-carrying component of hemoglobin to feed and grow aggressive AML in children.
Gene therapy for X-linked SCID resulted in the development of T cell, B cell and natural killer cells without side effects. Read more about the research.
Jun J. Yang, PhD, shares research presented at ASH that highlights the role the GATA3 oncogene plays in a high-risk subset of acute lymphoblastic leukemia.
The annual American Society of Hematology (ASH) meeting offers St. Jude clinicians and researchers the opportunity to learn, network and recruit. Read more.